CA125 in the monitoring of response to chemotherapy of ovarian carcinoma

M. Quaranta, V. Lorusso, M. Coviello, G. Micelli, A. Casamassima

Research output: Contribution to journalArticlepeer-review


CA125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of 11 patients who showed objective response to chemotherapy had a decrease in antigen levels. Two out of 3 patients with stable disease had unchanged values. Progression was always associated with rising levels. CA125 is a reliable marker for monitoring response to chemotherapy in advanced epithelial ovarian carcinoma.

Original languageEnglish
Pages (from-to)68-70
Number of pages3
JournalInternational Journal of Cancer
Issue numberSUPPL. 3
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'CA125 in the monitoring of response to chemotherapy of ovarian carcinoma'. Together they form a unique fingerprint.

Cite this